Insulet Corporation

NASDAQ:PODD

Medical - Devices

Healthcare
$139.98 -2.82%

-$4.17 today

Market cap
$9.71B
Beta
1.13
P/E (TTM)
33.2
EPS (TTM)
$4.33
52W Low $140.63High $354.88

Volume 2.09M

Average 1.32M

PODD Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Insulet CorporationNASDAQ: PODD

Net Receivables · Q2 FY2026 · quarter ended Jun 2026

Net receivables rises 32.4% from a year ago

Net receivables stood at $588.7M at the end of Q2 FY2026, up 32.4% from a year earlier and up 8.1% from the prior quarter. Over 3 fiscal years it compounded at +36.0% a year.

Context

  • Net receivables amounted to 18.6% of total assets at the end of Q2 FY2026, up 5.8 pp from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +32.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$588.7M+8.1% QoQ
Last fiscal yearDec 2025
$516.9M+41.4% YoY
Year agoJun 2025
$444.5M+32.4% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+32.4%——
1 year+41.4%——
3-year CAGR+36.0%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
516.9M USD
Year-over-year change
+41.4%
4-year CAGR
+33.9%

Net Receivables vs competitors

How PODD compares with its peers on the latest reported figures

  • PODD's Jun 2026 net receivables of $588.7M is the 2nd highest of the 5 companies compared; the peer median is $79.28M.
  • Its year-over-year change of +32.4% is the 3rd highest of 5, against a peer median of +36.8%.
  • Net receivables amounts to 18.6% of total assets for PODD, versus a peer median of 13.4%.
PODD Competitors Peer median
Net Receivables for PODD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DXCMDexCom, Inc.Jun 2026$1.28B -6.8%+19.7%19.9%
PODDInsulet CorporationJun 2026$588.7M +32.4%+36.0%18.6%
TNDMTandem Diabetes Care, Inc.Mar 2026$140.67M +11.1%+13.0%12.2%
BBNXBeta Bionics, Inc.Mar 2026$17.89M +62.4%—5.9%
SENSSenseonics Holdings, Inc.Mar 2026$15.05M +138.2%+64.6%14.6%
Peer median (excluding PODD) $79.28M+36.8%+19.7%13.4%

Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents791.6M623.9M650.7M953.4M716.1M
Short-term Investments050.8M53.5M00
Net Receivables161M205.6M359.7M365.5M516.9M
Inventory303.2M346.8M402.6M430.4M452.6M
Other Current Assets60.7M71.7M99.8M121.9M203.1M
Total Current Assets1.32B1.3B1.57B1.87B1.89B
Property, Plant & Equipment (Net)546.4M625.9M692.8M759.8M863.2M
Goodwill39.8M51.7M51.7M51.5M51.6M
Intangible Assets36.6M75.5M98.7M98.5M117.1M
Long-term Investments19.3M15M05.5M20.1M
Tax Assets000141.8M82.4M
Other Non-current Assets90.2M184.2M178.7M159.4M167.3M
Total Non-current Assets732.3M952.3M1.02B1.22B1.3B
Total Assets2.05B2.25B2.59B3.09B3.19B
Account Payables37.7M30.8M19.2M19.8M75M
Short-term Debt30.1M31.1M52.9M85.9M22.2M
Tax Payables00000
Deferred Revenue3.5M16.1M15.4M12M14M
Other Current Liabilities87.2M190.8M241.7M267.9M359.7M
Total Current Liabilities228.8M364.7M451.2M528.4M680.1M
Long-term Debt1.25B1.37B1.37B1.3B979.7M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.5M1.6M1.9M2M1.5M
Other Non-current Liabilities5.8M6.7M6.5M9.6M(35M)
Total Non-current Liabilities1.26B1.41B1.4B1.35B995.1M
Total Liabilities1.49B1.77B1.86B1.88B1.68B
Common Stock100K100K100K100K100K
Retained Earnings(649.5M)(584.3M)(378M)40.3M287.4M
Accumulated OCI(2.2M)20M8M(13.2M)13.2M
Other Stockholders Equity00000
Minority Interest00000
Total Equity556.3M476.4M732.7M1.21B1.52B
Total Debt1.29B1.43B1.45B1.42B1.05B
Net Debt494.9M808.9M798.1M468.6M334.7M

Insulet Corporation

NASDAQ:PODD

Intrinsic Alpha fair value

Locked

Current Price

$139.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.